ROYAL OAK – Tember Shea, Portfolio Manager for Invest Detroit Ventures, interviews Mike Klein, CEO of Genomenon, to discuss the latest news coming out of the Ann Arbor-based gene therapy company.

Mike Klein 

To listen, click on https://soundcloud.com/mike-brennan-841872555/e170-genomenon